Astellas Pharma logo

Astellas Pharma

ALPMF | OTC
Chart Builder DCF Calculator
$17.50
+$0.18 (+1.04%)
At close: Nov 16, 2026, 1:57 PM ET
$17.30
-$0.20 (-1.14%)
Pre-market: Nov 16, 2026, 9:32 AM ET
+1.04%

Rating

Updated: Nov 16, 2026
72
-0.9 pts
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #41/1021 (Top 4%)

Key Statistics

Market Data

Market Cap $31.38B
1D Range
17.25 17.50
52W Range
11.40 17.60

Valuation (TTM)

PE 12.83
PB 2.49
EV/EBITDA 6.93

Valuation (NTM)

Forward PE 12.93
Forward PEG 0.34
Price Target $0.00
Loading financial charts...

Profile

Astellas Pharma Inc. operates as a global pharmaceutical enterprise, encompassing the development, manufacturing, distribution, and commercialization of medicinal products across international markets...

Sector Healthcare
Employees 14,099
IPO Date Apr 26, 2010
Fiscal Year April - March

Latest News

Impax International Sustainable Economy Fund Q2 2026 Contributors And Detractors

3 months ago · seekingalpha.com

Impax International Sustainable Economy Fund Q2 2026 Contributors And Detractors

Earnings

Latest Earnings
Nov 4, 2026
EPS
$0.35
Miss -14.38%
REV
$4B
Beat +6.32%
Next Earnings
Feb 8, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.